Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 345

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 345
---
   |     |   |          544,629 |   |
| Machinery and office equipment                 |     |   |     1,465,855 |   |     |   |        1,423,183 |   |
| Software                                       |     |   |        72,394 |   |     |   |           72,394 |   |
|                                                |     |   |     2,253,485 |   |     |   |        2,210,813 |   |
| Less accumulated depreciation and amortization |     |   |    (2,101,505 | ) |     |   |       (2,087,447 | ) |
|                                                |     | $ |       151,980 |   |     | $ |          123,366 |   |

Depreciation and amortization of property and equipment totaled approximately $ 14,000 and $ 34,000 for the three months ended March 31, 2025, and 2024, respectively.

**Note 7-Accounts payable and accrued expenses**

Accounts payable and accrued expenses consist of the following as of March 31, 2025, and 2024:

|                        |     |   | March 31,2025 |     |   | December 31,2024 |
|:-----------------------|:----|:--|--------------:|:----|:--|-----------------:|
| Trade accounts payable |     | $ |     3,084,059 |     | $ |        3,152,816 |
| Accrued compensation   |     |   |     1,452,062 |     |   |        1,161,650 |
| Other accrued expenses |     |   |        81,499 |     |   |          855,700 |
|                        |     | $ |     4,617,620 |     | $ |        5,170,166 |

Note 8-Incometaxes Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets,